An Observation study of Thymoglobuline as Induction therapy in a steriod free maintenance immuno-supressive protocol for INDIAN patients undergoing live donor renal transplantation - OTIS-INDIA.

Trial Profile

An Observation study of Thymoglobuline as Induction therapy in a steriod free maintenance immuno-supressive protocol for INDIAN patients undergoing live donor renal transplantation - OTIS-INDIA.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Antithymocyte globulin (Primary)
  • Indications Transplant rejection
  • Focus Therapeutic Use
  • Acronyms OTIS-INDIA
  • Most Recent Events

    • 21 Mar 2012 Official title amended as reported by Clinical Trials Registry - India.
    • 27 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top